Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD
Tetsuya Akaishi(Tohoku University Hospital), Ichiro Nakashima(Tohoku University), Noriko Himori(Tohoku University), Ryo Ogawa(Fukushima Medical University), Toru Nakazawa(Tohoku University), Toshiyuki Takahashi(Fukushima Medical University), Takayuki Takeshita(Tohoku University), Tatsuro Misu(Fukushima Medical University), Kimihiko Kaneko(Fukushima Medical University), Kazuo Fujihara(Tohoku University), Masashi Aoki(Tohoku University), Michiaki Abe(Tohoku University Hospital), Juichi Fujimori(Fukushima Medical University), Tadashi Ishii(Fukushima Medical University)
Cited by 48
Related Papers
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
|Neurology Neuroimmunology & Neuroinflammation|2017|432
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
|Journal of Neurology Neurosurgery & Psychiatry|2018|199
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1
|Journal of Neurology Neurosurgery & Psychiatry|2015|141
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
|Journal of Neurology Neurosurgery & Psychiatry|2016|108